Literature DB >> 15272912

Proton magnetic resonance spectroscopy and single photon emission computed tomography study of the brain in asymptomatic young hyperlipidaemic Asian Indians in North India show early abnormalities.

Sanjeev Sinha1, Anoop Misra, Virendra Kumar, N R Jagannathan, C S Bal, Ravindra Mohan Pandey, Rohit Singhania.   

Abstract

OBJECTIVE: To evaluate brain metabolism and cerebral blood flow in young patients with hyperlipidaemia. PATIENTS AND METHODS: Proton magnetic resonance spectroscopy ((1)H MRS) and single photon emission computed tomography (SPECT) of the brain was carried out in 19 asymptomatic young patients with hyperlipidaemia (mean age 32.6 +/- 6.0 years, range 22-45 years) and 21 age-matched healthy controls divided into the following three groups; (i) hyperlipidaemics on pharmacological treatment (group 1, n = 13), (ii) hyperlipidaemics not on pharmacological treatment (group 2, n = 6) and (iii) control group of healthy subjects (group 3, n = 21).
RESULTS: No statistical difference was observed in the brain metabolite ratios between controls and hyperlipidaemic patients (both treatment naive and treated) in the (1)H NMR study. Two hyperlipidaemic patients showed a lactate peak and one had a lipid peak. The SPECT study was abnormal in seven hyperlipidaemic patients. In the pooled data, 50% subjects with high serum triglyceride (TG) levels as opposed to 14% subjects with normal serum TG levels showed cerebral hypoperfusion. The choline/creatine (Cho/Cr) ratio of the occipital region of the brain showed correlation with the excess percentage of body fat (%BF) and low levels of high density lipoprotein cholesterol (HDL-C) compared to those with normal %BF and normal HDL-C levels, respectively, in pooled data of all subjects. The N-acetyl aspartate (NAA)/Cho ratio also showed correlation with hypercholesterolaemia. Serum TG levels were positively correlated with the NAA/Cr ratio (r = 0.62, P < 0.05) and the Cho/Cr ratio (r = 0.63, P < 0.05) in the parieto-temporal area in group 1 patients.
CONCLUSION: The study revealed no difference in the brain metabolite ratios between controls and hyperlipidaemic patients, while some hyperlipidaemic patients showed abnormalities of cerebral blood flow. Brain metabolite ratios were also influenced by certain parameters of body composition and lipids. As abnormal body composition, hypertriglyceridaemia and low levels of HDL-C are prevalent in Asian Indians, such data are important and indicate a need for further study.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15272912     DOI: 10.1111/j.1365-2265.2004.02074.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

1.  Cerebellar glucose during fasting and acute hyperglycemia in nondiabetic men and in men with type 1 diabetes.

Authors:  Outi Heikkilä; Sari Mäkimattila; Marjut Timonen; Per-Henrik Groop; Sami Heikkinen; Nina Lundbom
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

2.  Risk for metabolic syndrome predisposes to alterations in the thalamic metabolism.

Authors:  Outi Heikkilä; Nina Lundbom; Marjut Timonen; Per-Henrik Groop; Sami Heikkinen; Sari Mäkimattila
Journal:  Metab Brain Dis       Date:  2008-07-22       Impact factor: 3.584

3.  Hypercholesterolemia enhances tolerance to lethal systemic hypoxia in middle-aged mice: possible role of VEGF downregulation in brain.

Authors:  Lei Xi; Shobha Ghosh; Xiaoyin Wang; Anindita Das; Frank P Anderson; Rakesh C Kukreja
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396

4.  Relationships between dietary nutrients intake and lipid levels with functional MRI dorsolateral prefrontal cortex activation.

Authors:  Huijin Lau; Suzana Shahar; Mazlyfarina Mohamad; Nor Fadilah Rajab; Hanis Mastura Yahya; Normah Che Din; Hamzaini Abdul Hamid
Journal:  Clin Interv Aging       Date:  2018-12-24       Impact factor: 4.458

Review 5.  Obesity and dyslipidemia in South Asians.

Authors:  Anoop Misra; Usha Shrivastava
Journal:  Nutrients       Date:  2013-07-16       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.